Combined effect of PCV10 and meningococcal C conjugate vaccination on meningitis mortality among children under five years of age in Brazil
The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in the Brazilian National Immunization Program in March 2010, scheduled at 2, 4, and 6 months, with a booster at 12–15 months of age. The meningococcal C conjugate vaccine (MCC) was introduced in November 2010, scheduled at 3 and 5 ...
Main Authors: | Ana Luiza Bierrenbach, Ruth Minamisava, Airlane Pereira Alencar, Gizelton Pereira Alencar, Ana Lucia Andrade |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-05-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2017.1391431 |
Similar Items
-
Trends in laboratory-confirmed bacterial meningitis (2012–2019): national observational study, EnglandResearch in context
by: Sathyavani Subbarao, et al.
Published: (2023-09-01) -
Assessing the Impact of TLR4 rs4986790 Polymorphism on Bacterial Meningitis Risk: A Systematic Review and Meta-Analysis
by: Praveen Kumar Chandra Sekar, et al.
Published: (2024-12-01) -
Meningococcal A conjugate vaccine coverage in the meningitis belt of Africa from 2010 to 2021: a modelling studyResearch in context
by: Rose G. Bender, et al.
Published: (2023-02-01) -
Cerebral vein thrombosis due to meningococcal meningitis
by: Atousa Hakamifard, et al.
Published: (2019-01-01) -
Pattern of the meningococcal meningitis outbreak in Northern Nigeria, 2009
by: Bassey Enya Bassey, et al.
Published: (2016-02-01)